source
- Eli Lilly commits $100M upfront in new five-target partnership with China's InnoCareEli Lilly has agreed to pay $100 million upfront and in the near term to Chinese biotech InnoCare Pharma as part of a five‑target drug discovery partnership. The agreement also provides for up to $…
- FDA warns Houston compounding pharmacy of unsanitary GLP-1 production risking contaminationFDA issued a warning letter to Empower Clinic Services, operating as Empower Pharmacy, after inspectors found unsanitary conditions at its Houston compounding site. Inspectors observed that the ph…